Teva is happy to announce the 2nd Nordic Migraine Symposium was successfully held fully online on 27 and 28 November 2020.
It was hosted by Teva Nordics Medical Affairs.
The topics and speakers have been selected by a Steering Committee consisting of leading migraine experts from the Nordic countries.
Professor of Neurology at Rigshospitalet Glostrup, Denmark.
Professor of Neurology in the Department of Neuroscience, Norwegian University of Science and Technology, Director of Tjörn Headache Clinic, Sweden.
Assistant Professor, Neurology specialist at Helsinki University Central Hospital and Helsinki Headache Center, Finland.
Anne Christine Poole
General practitioner and headache specialist at Oslo Headache Center AS, Norway.
If you have any questions regarding the symposium, please contact your local Teva medical representative:
On behalf of the Steering Committee and Teva Neuroscience
About the Nordic Migraine Symposium
Teva is a global company working in generics and specialty medicine, with focus on innovation in respiratory, pain and CNS. Teva is committed to bringing medicine, education and innovative solutions to health care professionals and with the ultimate goal of improving patient lives.
Aligned with this commitment, Teva Nordics has since 2013 arranged an annual scientific symposium within multiple sclerosis intended to be complementary to other international congresses and with highest clinical and scientific relevance. These symposia continue within the field of migraine having top international migraine experts in the steering committee and as speakers. We strive to provide the speakers an opportunity to present their work/research in an environment facilitating interactions and discussions.